| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4eaa45cb4c5bc0e9225e1ba49a5bc577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c1f487546fd1903e8a8762dce82be35 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 |
| filingDate |
2014-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e356ab71756e7c56c5828d92951877ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbfd534770c9b58d57cf109ae532eba4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be88d9e87da2522637d338b8faf21d6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b900d367408399dfda86be9dc3517f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db98ededece5bba30d115da8ab93d854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f16ae55fcd0889dd0210c66f190989df |
| publicationDate |
2016-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20160060227-A |
| titleOfInvention |
Composition for preventing or treating eye disease |
| abstract |
The present invention relates to a pharmaceutical composition comprising a hyaluronic acid crosslinked product and a health food composition, wherein the pharmaceutical composition has a remarkable effect on moisturizing and lubrication of eyes by improving the water content due to the improved viscoelasticity compared with the conventional eye drop composition And thus can be effectively used as eye drops and eye ointment for eye diseases such as conjunctival epithelial disorders. In addition, the pharmaceutical composition according to the present invention can be effectively used for the treatment of ocular dryness by inhibiting inflammation induced by corneal epithelial cells due to dry eye syndrome and restoring the wound. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11034801-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111315813-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111315813-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200143630-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019097427-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11324854-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019054850-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020250128-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101944008-B1 |
| priorityDate |
2014-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |